share_log

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

Enliven Therapeutics、Alpine Immunce Sciences、Janux Therapeutics和其他大股週四走高
Benzinga ·  04/11 22:01

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.

美國股市漲跌互現，道瓊斯指數週四下跌超過50點。

Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) rose sharply during Thursday's session.

Enliven Therapeutics, Inc.（納斯達克股票代碼：ELVN）的股價在週四的交易中大幅上漲。

Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.

Enliven Therapeutics 公佈了慢性髓系白血病的 ELVN-001 一期臨床試驗的概念驗證數據。

Enliven Therapeutics shares surged 26% to $24.97 on Thursday.

週四，Enliven Therapeutics股價飆升26％，至24.97美元。

Here are some other big stocks recording losses in today's session.

以下是今天交易日其他一些錄得跌幅的大型股票。

  • Rallybio Corporation (NASDAQ:RLYB) shares gained 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
  • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) jumped 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) shares jumped 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) rose 14.6% to $15.91.
  • AnaptysBio, Inc. (NASDAQ:ANAB) rose 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
  • Fiverr International Ltd. (NYSE:FVRR) gained 10.5% to $21.25 after the company's board authorized a $100 million share repurchase program.
  • GigaCloud Technology Inc. (NASDAQ:GCT) shares jumped 10.2% to $34.18.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) climbed 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
  • AlTi Global, Inc. (NASDAQ:ALTI) gained 9.3% to $5.06.
  • Nexxen International Ltd. (NASDAQ:NEXN) rose 7.3% to $5.62.
  • StepStone Group LP (NASDAQ:STEP) gained 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.
  • Frontline plc (NYSE:FRO) rose 5.9% to $24.47.
  • IAMGOLD Corporation (NYSE:IAG) gained 3.6% to $3.74.
  • Rallybio Corporation（納斯達克股票代碼：RLYB）股價上漲89.6％，至3.09美元，此前該公司宣佈與強生公司合作，爲面臨FNAIT風險的孕婦推進治療方案。
  • 在Vertex簽訂收購阿爾卑斯免疫科學公司（納斯達克股票代碼：ALPN）的協議後，該公司上漲36.6％，至64.25美元。
  • Janux Therapeutics, Inc.（納斯達克股票代碼：JANX）股價上漲16.8％，至52.15美元，此前週三有報道稱該公司正在權衡可能的出售。
  • Gyre Therapeutics, Inc.（納斯達克股票代碼：GYRE）上漲14.6％，至15.91美元。
  • AnaptysBio, Inc.（納斯達克股票代碼：ANAB）上漲11.4％，至24.72美元。富國銀行分析師德里克·阿奇拉以增持評級啓動了對AnaptysBio的報道，並宣佈目標股價爲56美元。
  • Fiverr International Ltd.（紐約證券交易所代碼：FVRR）上漲10.5％，至21.25美元，此前該公司董事會批准了一項1億美元的股票回購計劃。
  • GigaCloud Technology Inc.（納斯達克股票代碼：GCT）股價上漲10.2％，至34.18美元。
  • Nurix Therapeutics, Inc.（納斯達克股票代碼：NRIX）上漲9.6％，至17.21美元。貝爾德分析師喬爾·比蒂維持Nurix Therapeutics的跑贏大盤，並將目標股價從24美元上調至25美元。
  • ALTi Global, Inc.（納斯達克股票代碼：ALTI）上漲9.3％，至5.06美元。
  • 耐克森國際有限公司（納斯達克股票代碼：NEXN）上漲7.3％，至5.62美元。
  • 摩根大通將股票從中性上調至增持後，StepStone Group LP（納斯達克股票代碼：STEP）上漲7.1％，至37.46美元。
  • Frontline plc（紐約證券交易所代碼：FRO）上漲5.9％，至24.47美元。
  • IAMGOLD Corporation（紐約證券交易所代碼：IAG）上漲3.6％，至3.74美元。

Now Read This: Dell, Designer Brands And 2 Other Stocks Insiders Are Selling

現在讀這個： 戴爾、設計師品牌和其他兩隻股票內部人士正在拋售

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論